相关实验视频

Updated: Jul 1, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

住院患者持续葡萄糖监测的成本效益

David Veríssimo¹, Beatriz R Pereira¹, Joana Vinhais¹

¹Department of Endocrinology, Hospital das Forças Armadas, Lisbon, PRT.

|March 13, 2024

概括

持续血糖监测 (CGM) 改善了住院2型糖尿病患者的血糖控制. 这种成本效益分析表明,CGM是一种比传统血糖监测更实惠的选择.

科学领域:

内分泌学在内分泌学.
卫生经济学卫生经济学
医疗技术医疗技术医学技术

背景情况:

在密集胰岛素治疗中治疗2型糖尿病的住院血糖控制仍然是一个挑战.
与毛细血管血糖监测相比,持续血糖监测 (CGM) 已证明改善了血糖结果.
在住院治疗中,CGM的成本效益需要进一步研究.

研究的目的:

为了比较CGM与毛细血管血糖监测的成本效益,以实现2型糖尿病住院患者的血糖控制.
分析特定的血糖目标的成本效益,包括范围内的时间和在目标范围内,以下和以上的读数的百分比.

主要方法:

在葡萄牙一家医院进行了一项回顾性队列研究.
血糖控制是由特定的目标定义的,读数在范围内 (>70%),范围以下 (<4%),严重低血糖 (<1%),范围以上 (<25%) 和非常高的读数 (<5%).
根据实现血糖目标的患者数量和特定的时间范围指标来评估成本效益.

主要成果:

对于主要结果,CGM显示每效果的中位数成本较低 (11.1欧元与34.9欧元/患者).
对于达到范围内的读数 (7.8欧元对11.6欧元/患者) 和"范围以上"目标 (7.4欧元对9.9欧元/患者对>180毫克/毫升和6.9欧元对17.4欧元/患者对>250毫克/毫升) 的读数,CGM与较低的成本有关.

结论:

本研究提出了首次对CGM设备在住院环境中的成本效益分析.
CGM与改善的血糖控制有关,与毛细血管血糖监测相比,这是一个更具成本效益的选择.
这些发现支持将CGM设备集成到医院环境中,以管理住院患者的2型糖尿病.

关键词:

不断监测葡萄糖的情况.经济效益性经济效益性在医院住院的患者.葡萄牙葡萄牙 2 型糖尿病 2 型糖尿病

更多相关视频

Simple Continuous Glucose Monitoring in Freely Moving Mice

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

相关概念视频

Pulse rhythm

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...